CVS Health Corporation (NYSE:CVS) – Stock analysts at Leerink Swann decreased their FY2018 EPS estimates for CVS Health Corporation in a report released on Tuesday. Leerink Swann analyst D. Larsen now expects that the pharmacy operator will post earnings per share of $6.40 for the year, down from their previous forecast of $6.45. Leerink Swann currently has a “Buy” rating and a $90.00 target price on the stock.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.02. The company had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation’s revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.32 earnings per share. ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/leerink-swann-brokers-reduce-earnings-estimates-for-cvs-health-corporation-cvs/1616578.html.

A number of other research firms have also issued reports on CVS. Cowen and Company restated an “outperform” rating and issued a $86.00 target price on shares of CVS Health Corporation in a report on Tuesday, June 13th. Royal Bank Of Canada started coverage on CVS Health Corporation in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price for the company. Robert W. Baird restated an “outperform” rating and issued a $90.00 target price on shares of CVS Health Corporation in a report on Monday, August 14th. Loop Capital started coverage on CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price for the company. Finally, Jefferies Group LLC increased their target price on CVS Health Corporation from $82.00 to $86.00 and gave the company a “hold” rating in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $89.56.

Shares of CVS Health Corporation (CVS) opened at 76.92 on Friday. The stock has a market cap of $78.19 billion, a P/E ratio of 15.32 and a beta of 0.92. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $88.92. The stock has a 50 day moving average price of $79.64 and a 200-day moving average price of $79.03.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of CVS Health Corporation by 1.4% in the second quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock valued at $6,159,825,000 after purchasing an additional 1,056,265 shares in the last quarter. FMR LLC increased its holdings in shares of CVS Health Corporation by 22.0% in the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after purchasing an additional 5,446,930 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of CVS Health Corporation by 1.8% in the first quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock valued at $1,759,338,000 after purchasing an additional 398,999 shares in the last quarter. Northern Trust Corp increased its holdings in shares of CVS Health Corporation by 5.5% in the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock valued at $1,256,631,000 after purchasing an additional 807,639 shares in the last quarter. Finally, Nordea Investment Management AB increased its holdings in shares of CVS Health Corporation by 8.4% in the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after purchasing an additional 1,100,373 shares in the last quarter. 81.49% of the stock is owned by institutional investors.

In other news, insider Larry J. Merlo sold 241,150 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the completion of the sale, the insider now owns 299,255 shares of the company’s stock, valued at $24,859,112.85. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard J. Swift sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now directly owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 716,625 shares of company stock valued at $58,318,431. Company insiders own 0.61% of the company’s stock.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. The ex-dividend date is Monday, October 23rd. CVS Health Corporation’s payout ratio is 39.92%.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Earnings History and Estimates for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.